A new study shows that treatment with an immune-boosting protein called interleukin 7 (IL-7) in combination with radiation improves survival in mice with glioblastoma. The study in mice suggests promise for a phase 1/2 clinical trial that is investigating a long-acting type of IL-7 in patients with glioblastoma.
Scientists describe T. adhaerens‘ unusual behavior, including its capacity to repair its DNA even after significant radiation damage and to extrude injured cells, which later die. The findings advance scientific investigations of natural cancer-suppression mechanisms across life. Insights gleaned from these evolutionary adaptations may find their way into new and more effective therapies for this leading killer.
Immune checkpoint inhibitors strengthen the immune response against cancer cells, but the medications are ineffective against certain tumors. Results from a new clinical trial indicate that adding radiation may overcome this resistance to immune checkpoint inhibitors.
Which are the best applications for tumor therapy with charged particles to realize its great potential for the future? In which cases can it be used most effectively? These aspects belong to the most exciting questions in radiation biology and medical physics. A group of top-class experts now evaluated and summarized the state-of-the-art of heavy ion radiotherapy and presented a review article in the world-renowned online journal „Nature Reviews“. Main author of the text with the title „Physics and biomedical challenges of cancer therapy with accelerated heavy ions“ is Professor Marco Durante, Head of the GSI Biophysics Research Department.
Studying mice, researchers have developed a method of stem cell transplantation that does not require radiation or chemotherapy. Instead, the strategy takes an immunotherapeutic approach, combining the targeted elimination of blood-forming stem cells in the bone marrow with immune-modulating drugs to prevent the immune system from rejecting the new donor stem cells.
Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of radiation therapy in cancer patients with brain metastases, in a proof-of-concept, randomized clinical trial.
Researchers have developed a new test to more easily diagnose medulloblastoma, the most common malignant childhood brain tumor. The test — which can distinguish between extremely high-risk medulloblastoma cases that need radiation therapy from those that are lower-risk and do not need radiation — could help pave the way for personalized treatment options for children suffering from the disease. It relies on an antibody-based technique called immunohistochemistry which is widely available in clinical laboratories around the world.
New X-ray technology first used with patients – Dark-field X-ray technology improves diagnosis of pulmonary ailments
For the first time, researchers at the Technical University of Munich (TUM) have successfully used a new X-ray method for respiratory diagnostics with patients. Dark-field X-rays visualize early changes in the alveolar structure caused by the lung disease COPD and require only one fiftieth of the radiation dose typically applied in X-ray computed tomography. This permits broad medical application in early detection and treatment follow-up of respiratory ailments.
Researchers fabricate gold nanoparticles with a rapidly decaying radioisotope that can be internalized by cancer cells. Because the radiation remains strongly localized, high doses can be administered without concern for side effects. This research may lead to safer and more effective treatments for many types of cancer.
Known as pediatric radiation-induced high-grade gliomas (RIGs), this specific type of brain tumor is caused by cranial radiation therapy for other cancers, most often brain cancers. They account for nearly 4% of all childhood brain tumor deaths, but there have not been many studies on RIGs and how to treat them.
New research suggests that radiation therapy can reprogram heart muscle cells to what appears to be a younger state, fixing electrical problems that cause a life-threatening arrhythmia without the need for a long-used, invasive procedure.
Cancer physicians are pioneering a new PULSAR radiation-therapy strategy that improves tumor control compared with traditional daily therapy.
As the complexity of radiation therapy has grown, so too has the amount of data that goes into treatment machines. With more data comes more opportunity for errors in data transfer. A medical physics researcher is working to make those errors less likely.
Research suggests that children with average risk medulloblastoma can receive radiation to a smaller volume of the brain at the end of a six-week course of treatment and still maintain the same disease control as those receiving radiation to a larger area. But the dose of preventive radiation treatments given to the whole brain and spine over the six-week regimen cannot be reduced without reducing survival.
A new treatment has potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer. These results represent the first time a PARP inhibitor has been shown to significantly reduce the risk of breast cancer returning in high-risk patients following completion of standard chemotherapy, surgery and radiation therapy.
Nano-sized particles have been engineered in a new way to improve detection of tumors within the body and in biopsy tissue, a research team reports. The advance could enable identifying early stage tumors with lower doses of radiation.
Although sun radiation was relatively low, the temperature on the young Earth was warm. An international team of geoscientists has found important clues that high levels of carbon dioxide in the atmosphere were responsible for these high temperatures. It only got cooler with the beginning of plate tectonics, as the CO2 was gradually captured and stored on the emerging continents.
A small drug molecule that appears to protect normal tissue from the damaging effects of radiation, may simultaneously be able to boost the cancer-killing effect of radiation therapy, according to a new study.
Researchers utilized genomic tools to investigate potential health effects of exposure to ionizing radiation, a known carcinogen, as a result of the 1986 Chernobyl accident. One study found no evidence that genetic changes associated with radiation exposure are passed to children, while the second study documented the genetic changes in the tumors of people who developed thyroid cancer after being exposed as children or fetuses to the radiation released by the accident. Findings are being published close to the 35th anniversary of the Chernobyl disaster.
New data suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B radiation from the sun.
Nothing for the garbage can – Hof scientists want to research environmentally friendly plastic products from biowaste
Will there soon be packaging in the supermarket made with biowaste from local cideries or agricultural film with coffee grounds? At the Institute for Biopolymers and Sustainability at Hof University (ibp) a junior research group wants to explore the influence of natural radiation and biogenic residues on the properties and structure of biopolymers. This could make these bioplastics interesting for a sustainable product economy in the future. Among other things, biowaste from the food industry and forestry is to be used in bioplastic blends and thus fed into a natural reuse.
A radioactive bone cement that’s injected into bone to provide support and local irradiation is proving to be a safer alternative to conventional radiation therapy for bone tumors, according to a new study.
Exposure to radiation can wreak indiscriminate havoc on cells, tissues, and organs. Curiously, however, some tissues are more vulnerable to radiation damage than others. A new study now finds that cellular survival after radiation exposure depends on behavior of the tumor-suppressor protein p53 over time. In vulnerable tissues, p53 levels go up and remain high, leading to cell death. In tissues that tend to survive radiation damage, p53 levels oscillate up and down.
The strength and beauty of mother-of-pearl, also known as nacre, comes from its remarkably regular and uniform architecture. Until now, it was unclear how this intricate structure could be built by a multitude of single cells, all secreting materials at different locations at the same time. In a new study published in Nature Physics, researchers from the B CUBE – Center for Molecular Bioengineering at TU Dresden and European Synchrotron Radiation Facility (ESRF) in Grenoble describe, for the first time, that structural defects in self-assembling nacre attract and cancel each other out, eventually leading to a perfect periodic structure.